Previous close | 22.35 |
Open | 22.35 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 85.00 |
Expiry date | 2024-01-19 |
Day's range | 22.35 - 22.35 |
Contract range | N/A |
Volume | |
Open interest | 34 |
Novavax gets green light from FDA, awaits CDC recommendation for booster COVID doses.
The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.
(Bloomberg) -- Novavax Inc.’s updated version of its Covid-19 shot gained US regulators’ authorization for emergency use amid a rocky rollout of competitors’ offerings.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsKevin McCarthy Ousted as US House Speaker by Republican DissidentsWall Street Fear Gauge Ratchets Up After Jobs Data: Markets WrapWhy a US Recession Is Still Likely — and Coming SoonAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.Th